Renin-angiotensin system inhibitors prescriptions in Chinese hospitalized chronic kidney disease patients

doi:10.12998/wjcc.v12.i17.3061

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (912)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

509

Figures (1-7)

Tables (1-4)

Sum=713

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

119

Sum=167

Jun 16, 2024 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jun 16, 2024; 12(17): 3061-3075
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3061

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow chart of patient selection. CKD: Chronic kidney disease; DM: Diabetes mellitus.

Open in New Tab Full Size Figure Download Figure

Figure 2 Trends of the frequency of renin-angiotensin system inhibitors prescriptions from 2010 to 2019, in all patients included in the analysis, guideline-recommended patients, elderly patients. CKD: Chronic kidney disease; RASI: Renin-angiotensin system inhibitors.

Open in New Tab Full Size Figure Download Figure

Figure 3 Trends of the frequency of renin-angiotensin system inhibitors prescriptions from 2010 to 2019 in patients where different methods for detecting proteinuria were used. RASI: Renin-angiotensin system inhibitors; ACR: Albumin to creatinine ratio.

Open in New Tab Full Size Figure Download Figure

Figure 4 Trends of the frequency of renin-angiotensin system inhibitors prescriptions from 2010 to 2019 in the guideline-recommended chronic kidney disease patients of different age groups. RASI: Renin-angiotensin system inhibitors.

Open in New Tab Full Size Figure Download Figure

Figure 5 Trends of the frequency of renin-angiotensin system inhibitors prescriptions from 2010 to 2019 in guideline-recommended patients in different admission departments. RASI: Renin-angiotensin system inhibitors.

Open in New Tab Full Size Figure Download Figure

Figure 6 Trends of the frequency of renin-angiotensin system inhibitors prescriptions from 2010 to 2019 in guideline-recommended patients with different chronic kidney disease etiologies. RASI: Renin-angiotensin system inhibitors; DM: Diastolic blood pressure; HF: Heart failure.

Open in New Tab Full Size Figure Download Figure

Figure 7 Comparisons of renin-angiotensin system inhibitors prescriptions among patients with different chronic kidney disease stages, in all patients included in the analysis, guideline-recommended patients, and elderly patients. CKD: Chronic kidney disease; RASI: Renin-angiotensin system inhibitors.

Citation: Zhang C, Duan ZY, Nie SS, Zhang Z, Guo XR, Zhang CY, Dong J, Cai GY. Renin-angiotensin system inhibitors prescriptions in Chinese hospitalized chronic kidney disease patients. World J Clin Cases 2024; 12(17): 3061-3075
URL: https://www.wjgnet.com/2307-8960/full/v12/i17/3061.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i17.3061